HPV Vaccines
Human Papillomavirus (HPV) vaccine is an inactivated (not live) vaccine which protects against four major types of HPV.
These include two types that cause about 70% of cervical cancer and two types that cause about 90% of genital warts. HPV vaccine can prevent most genital warts and most cases of cervical cancer. Protection from HPV vaccine is expected to be long-lasting. But vaccinated women still need cervical cancer screening because the vaccine does not protect against all HPV types that cause cervical cancer.
Routine HPV Vaccination
- HPV vaccine is routinely recommended for girls 11 and 12 years of age
- The HPV4 vaccine (the type recommended for prevention of genital warts in girls) may also be given in three doses to boys aged 9 to 26.
It is important for girls to get HPV vaccine before their first sexual contact -- because they have not been exposed to HPV. For these girls, the vaccine can prevent almost 100% of disease caused by the four types of HPV targeted by the vaccine. However, if a girl or woman is already infected with a type of HPV, the vaccine will not prevent disease from that type. The vaccine is also recommended for girls and women 13 through 26 years of age who did not receive it when they were younger.
- Advances in HPV Vaccine
- HPV Vaccines for Men
- HPV Vaccine risks and controversies
- HPV Vaccine for Women
Related Conference of HPV Vaccines
4th International Conference on Vaccines, Immunization and Clinical Trials
HPV Vaccines Conference Speakers
Recommended Sessions
- Cancer Vaccines and Immunotherapy
- Childhood and Maternal Vaccines
- DNA Vaccines
- Hepatitis Vaccines
- HIV/AIDS Vaccines
- HPV Vaccines
- Human Preventive & Therapeutic Vaccines
- Human Vaccines - Infectious & Non Infectious Diseases
- Immunology/Animal Models
- Mucosal Vaccines
- Next-Generation Vaccines Delivery Technologies
- Plant-based Vaccines
- Travel Immunization
- Vaccine Adjuvants
- Vaccine Research & Development
- Vaccine Safety & Efficacy
- Vaccines against Vector-borne Diseases
- Vaccines against Viral & Bacterial Diseases
- Vaccines Business Development
- Vaccines for Older Adults
- Vaccines for Respiratory Diseases
- Veterinary Vaccines
Related Journals
Are you interested in
- Animal Models and Biological Research - Vaccines R&D 2021 (Netherlands)
- Bioinformatics and Biotherapeutics - Vaccines R&D 2021 (Netherlands)
- Biomarkers and Case Reports - Vaccines R&D 2021 (Netherlands)
- Cancer Vaccines and Immunotherapy - Euro Vaccines 2021 (Spain)
- Cancer, Malaria & TB Vaccines - Vaccines World 2021 (France)
- Childhood Vaccines and Maternal Vaccines - Euro Vaccines 2021 (Spain)
- Clinical Trials, Research and Development - Vaccines R&D 2021 (Netherlands)
- Combination & Conjugate Vaccines - Vaccines World 2021 (France)
- Coronavirus (Covid 19) and Next Generation Vaccines - Vaccines R&D 2021 (Netherlands)
- COVID-19 Vaccine Research & Development - Euro Vaccines 2021 (Spain)
- DNA & Synthetic Vaccines - Vaccines World 2021 (France)
- DNA Vaccines - Euro Vaccines 2021 (Spain)
- Emerging and Infectious Diseases - Vaccines R&D 2021 (Netherlands)
- Hepatitis Vaccines - Euro Vaccines 2021 (Spain)
- HIV Vaccines - Vaccines World 2021 (France)
- HIV Vaccines and Policy Issues - Vaccines R&D 2021 (Netherlands)
- HIV/AIDS Vaccines - Euro Vaccines 2021 (Spain)
- Human Preventive & Therapeutic Vaccines - Euro Vaccines 2021 (Spain)
- Human Vaccines - Infectious & Non Infectious Diseases - Euro Vaccines 2021 (Spain)
- Immunization and Bioprocessing - Vaccines R&D 2021 (Netherlands)
- Immuno-Oncology and Immunotherapy - Vaccines R&D 2021 (Netherlands)
- Immunology/Animal Models - Euro Vaccines 2021 (Spain)
- Influenza and Respiratory Vaccines - Vaccines R&D 2021 (Netherlands)
- Live Attenuated and Inactivated Vaccines - Vaccines R&D 2021 (Netherlands)
- Manufacturing, Production, and Delivery Technologies - Vaccines R&D 2021 (Netherlands)
- Mucosal Vaccines - Euro Vaccines 2021 (Spain)
- New Trends in Vaccines Development - Vaccines World 2021 (France)
- Next-Generation Vaccine Delivery Technologies - Euro Vaccines 2021 (Spain)
- Pediatric Vaccination - Vaccines World 2021 (France)
- Pediatric Vaccines - Vaccines World 2021 (France)
- Public Health and Patient Safety - Vaccines R&D 2021 (Netherlands)
- RDT in Antibiotic Research - Vaccines World 2021 (France)
- Regulatory Licensing and Scientific Affairs - Vaccines R&D 2021 (Netherlands)
- Side-effects of Vaccines - Vaccines World 2021 (France)
- Subunit/Conjugate and Toxoid Vaccines - Vaccines R&D 2021 (Netherlands)
- Toxoid Vaccines - Vaccines World 2021 (France)
- Translational Research on Pandemic Outbreaks - Vaccines R&D 2021 (Netherlands)
- Vaccine Adjuvants - Euro Vaccines 2021 (Spain)
- Vaccine Adjuvants and Antibody Engineering - Vaccines R&D 2021 (Netherlands)
- Vaccine Hesitancy and Health Literacy - Vaccines R&D 2021 (Netherlands)
- Vaccine Production & Development - Vaccines World 2021 (France)
- Vaccine Research & Development - Euro Vaccines 2021 (Spain)
- Vaccine Safety & Efficacy - Vaccines World 2021 (France)
- Vaccine Safety and Efficacy - Vaccines R&D 2021 (Netherlands)
- Vaccines - Vaccines World 2021 (France)
- Vaccines Against Infectious Diseases - Vaccines World 2021 (France)
- Vaccines against Viral and Bacterial Diseases - Euro Vaccines 2021 (Spain)
- Vaccines Business Development - Euro Vaccines 2021 (Spain)
- Vaccines for Older Adults - Euro Vaccines 2021 (Spain)
- Vaccines for Pregnant Women - Vaccines World 2021 (France)
- Vaccines for Respiratory Diseases - Euro Vaccines 2021 (Spain)
- Vaccines for Unconventional Diseases - Vaccines World 2021 (France)
- Vaccines for Vector-borne Diseases - Euro Vaccines 2021 (Spain)
- Vaccines Manufacturing Technologies - Vaccines World 2021 (France)
- Vaccines Research and Clinical Trails - Vaccines World 2021 (France)
- Vaccines safety & Efficacy - Euro Vaccines 2021 (Spain)
- Veterinary Vaccines - Euro Vaccines 2021 (Spain)
- Veterinary Vaccines and Animal Health - Vaccines R&D 2021 (Netherlands)
- Viral Vaccines and Bacterial Vaccines - Vaccines R&D 2021 (Netherlands)
- Virology and Antiviral Drugs - Vaccines R&D 2021 (Netherlands)
- Zika Virus Vaccines - Vaccines World 2021 (France)